MedPath

Comparison of Platelet Rich in growth factor and Hyaluronic acid in patients with knee osteoarthritis

Phase 3
Conditions
Knee osteoarthritis (Gonarthrosis).
Gonarthrosis [arthrosis of knee]
Registration Number
IRCT2016071513442N11
Lead Sponsor
Physical Medicine and Rehabilitation Department of Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

arthralgia since the past 3 months; radiologic evidence of articular damage (grade 2,3 of Kellgren-Lawrence scale) based on knee OA criteria of ACR. Exclusion criteria: systemic diseases such as diabetes mellitus and collagen vascular disorders; history or presence of cancer or malignant disorders; any infection and active wound of the knee; presence of immunosuppressive, autoimmune and platelet disorders; treatment with anticoagulant and anti-platelet medications 10 days before injection; use of NSAIDs 2 days before injection; history of knee articular injections of corticosteroids 3 weeks or use of systemic corticosteroids 2 weeks before PRP injections; hemoglobin measures of less than 12 g/dl and platelet counts of less than 150,000 per micro liter; recent history of severe trauma to the knee; age less than 45 or over 75 year; history of vasovagal shock; pregnancy; breastfeeding; genu valgum/varum greater than 20 degrees.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Knee pain. Timepoint: before intervention, 2 months & 6 months after intervention. Method of measurement: WOMAC questionnaire.;Function. Timepoint: before intervention, 2 months & 6 months after intervention. Method of measurement: WOMAC questionnaire.;The maximum distance of walking. Timepoint: before intervention, 2 months & 6 months after intervention. Method of measurement: Lequesne Index.;Activity of daily living. Timepoint: before intervention, 2 months & 6 months after intervention. Method of measurement: Lequesne Index.;Joint Stiffness. Timepoint: before intervention, 2 months & 6 months after intervention. Method of measurement: WOMAC questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath